SS-31 research material, shown as a boxed pen, with preclinical papers on the named compound.
Pen imagery is illustrative, based on supplied reference photographs. It does not verify the final supplied hardware, fill or strength.
Supplied for laboratory and scientific research only. Not for human or veterinary use.
Product specifications
Name
SS-31
Category
Research pen
Listed amount
5 mg total per pen
Format
Boxed research pen concept — final fill and concentration are unconfirmed
Classification
Supplied for laboratory and scientific research only. Not for human or veterinary use.
Shipping and support
Free UK delivery when you spend £25 or more. Eligible in-stock orders are dispatched the same working day, with tracked delivery available to selected European destinations.
Choose your country at checkout to confirm product availability and delivery charges.
Delivery windows are estimates, not guarantees. Dispatch is not the same as delivery, and customs clearance is not controlled by Zynx.
Documentation
Supporting quality documentation is displayed where available.
Published papers describe research on the named compound or related molecules. They do not test, certify or endorse the specific material shown on this page, and they do not make the material approved for personal use.
Human randomised trial
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
Neurology, 2023
Study model: Adults with genetically confirmed primary mitochondrial myopathy
A phase 3 randomised trial of elamipretide in primary mitochondrial myopathy. The published report did not meet its primary efficacy endpoints versus placebo.
This trial studied a clinical formulation of elamipretide in a defined disease population. It does not test the listed research material and does not make that material approved for personal use.
